Latest news for Searchlight Res (OTC:SCLTF) Stock

Searchlight Resources Inc is a Canadian mineral exploration and development company focused in Saskatchewan, Canada. Its exploration focus is on gold, uranium and battery minerals throughout the Province. It also holds an interest in Kulyk Lake South; Bootleg Lake Gold Property, Robinson Creek; Wapawekka Lake Greenstone Belt, Munro Warden Copper Nickel Cobalt Property, Cameron Cobalt Property, Duddridge Lake Property, Flin Flon North Project, and English Bay Property in Canada.

SEARCHLIGHT RES INC by Searchlight Resources Inc.

Searchlight Resources Inc

The Nasdaq 100 closed higher by over 1% during Friday's session. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Below is a look at a few recent notable insider sales. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Roblox</h3>
<ul>
<li>The Trade: Roblox Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) Director Gregory Baszucki <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 13,000 shares</a> at an average price of $40.45. The insider received around $525,847 from selling those shares.</li>
<li>What's Happening: Roblox will report the company&#8217;s second quarter financial results before the opening bell on Thursday, Aug. 1.</li>
<li>What Roblox Does: Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or &#8220;experiences&#8221;) for other players.</li>
</ul>
Have a look at our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<h3 class="wp-block-heading">Morgan Stanley</h3>
<ul>
<li>The Trade: Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) Chief Human Resources Officer Mandell Crawley <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 3,500 shares</a> at an average price of $105.25. The insider received around $368,375 from selling those shares.</li>
<li>What's Happening: On July 24, Morgan Stanley Expansion Capital acquired a stake in global payments fintech Sokin.</li>
<li>What Morgan Stanley Does: Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924.</li>
</ul>
<h3 class="wp-block-heading">Webster Financial</h3>
<ul>
<li>The Trade: Webster Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBS#NYSE">WBS</a>) Chief Credit Officer Jason A. Soto <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 1,650 shares</a> at an average price of $46.32. The insider received around $76,428 from selling those shares.</li>
<li>What's Happening: On July 23, Webster Financial reported worse-than-expected second-quarter financial results.</li>
<li>What Webster Financial Does: Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania.</li>
</ul>
<h3 class="wp-block-heading">Intercontinental Exchange</h3>
<ul>
<li>The Trade: Intercontinental Exchange, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) Chief Accounting Officer James W Namkung <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 1,043 shares</a> at an average price of $150.00. The insider received around $156,450 from selling those shares.</li>
<li>What's Happening: On July 10, Barclays analyst Benjamin Budish maintained Intercontinental Exchange with an Overweight and raised the price target from $150 to $159.</li>
<li>What Intercontinental Exchange Does: Intercontinental Exchange is a vertically integrated operator of financial exchanges and provides ancillary data products.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984459/top-3-risk-off-stocks-that-are-set-to-fly-in-july">Top 3 Risk Off Stocks That Are Set To Fly In July</a></li>
</ul>

News

Short Ideas

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

RBLX

Roblox, Morgan Stanley And 2 Other Stocks Insiders Are Selling

Stocks of cryptocurrency firms listed in New York surged Monday following statements from Republican presidential candidate Donald Trump, who supported Bitcoin (CRYPTO: BTC/USD) and promised <a target="_blank" href="https://www.benzinga.com/markets/cryptocurrency/24/07/40002734/trump-says-bitcoin-will-skyrocket-like-never-before-if-he-returns-to-the-white-house-promi" rel="noreferrer noopener">more favorable regulations</a> for the industry.
Trump&#8217;s remarks led to a notable rise in the shares of several crypto-related companies, Reuters reports.
Coinbase Global, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) and Marathon Digital Holdings, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) shares climbed over 4%, while miners Bitfarms Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BITF#NASDAQ">BITF</a>), Riot Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>), and CleanSpark Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) saw increases ranging from 4% &#8211; 5%.
During his campaign, Trump promised to create a national &#8220;stockpile&#8221; of bitcoin using the U.S. government&#8217;s current crypto assets.
He also intended to ensure that all remaining bitcoin is mined in the US.
Trump also pledged to fire the Securities and Exchange Commission (SEC) Chair Gary Gensler, who had defended the strict regulatory measures, pointing to the volatility and speculative nature of cryptocurrencies like bitcoin.
Bernstein analysts noted that the crypto market views a potential Trump presidency as positive for the industry, given the Biden administration&#8217;s regulatory crackdown and Trump&#8217;s supportive statements.
The broader acceptance of crypto, bolstered by institutional investors and the approval of exchange-traded funds tied to bitcoin and ether prices, has already moved the industry closer to mainstream finance. A Trump win could further accelerate this trend, Reuters writes.
Additionally, bitcoin&#8217;s price jumped as much as 2.4%, reaching its highest level since mid-June.
Investors can gain exposure to bitcoin through iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) and ProShares Bitcoin Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITO#NYSE">BITO</a>).
Price Action: COIN shares are trading higher by 3.82% to $252.22 premarket at the last check on Monday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Government

Regulations

Movers

Media

BITF

BITO

CLSK

COIN

IBIT

MARA

RIOT

Crypto Related Stocks Like Coinbase, Marathon Digital And Others Surge After Trump's Pro-Bitcoin Comments

In a significant move, President Joe Biden has put forth a three-part proposal aimed at reforming the Supreme Court. The proposal includes term limits for justices, a binding ethics code, and a constitutional amendment to hold presidents accountable for crimes committed while in office.
What Happened: Biden&#8217;s proposed amendment, known as the &#8220;No One Is Above the Law Amendment,&#8221; is a direct response to a <a href="https://www.benzinga.com/news/24/07/39587154/biden-slams-supreme-court-decision-that-gives-partial-immunity-to-trump-there-are-no-kings-in-americ">recent Supreme Court</a> ruling that granted immunity to former President Donald Trump for &#8220;official acts&#8221; committed during his presidency, CNBC<a href="https://www.cnbc.com/2024/07/29/biden-rolls-out-plan-to-overhaul-the-supreme-court.html?taid=66a761caf7c6ff000117e1eb&amp;utm_campaign=trueanthem&amp;utm_medium=social&amp;utm_source=twitter%7Cmain"> reported</a> on Monday.
The ethics code proposal comes in the wake of scandals involving Supreme Court justices Clarence Thomas and Samuel Alito, who were implicated in undisclosed financial gifts that raised serious conflict of interest concerns.
See Also: <a href="https://www.benzinga.com/news/24/07/39996908/trump-vs-harris-new-poll-shows-ex-president-leading-democratic-candidate-by-a-narrow-margin-but-vice?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Vs. Harris: New Poll Shows Ex-President Leading Democratic Candidate By A Narrow Margin, But Vice President&#8217;s Favorability Is Faring Better Than Biden</a>
After withdrawing from the presidential race and endorsing Vice President Kamala Harris, Biden has stated that Supreme Court reform is a top priority for his remaining time in office. However, these proposals will need congressional approval, a difficult task given the current partisan divide in Congress. A new constitutional amendment, in particular, requires a two-thirds majority approval from both the House and the Senate.
Biden is set to discuss his reform proposals in a speech at the LBJ Presidential Library in Texas later on Monday.
Why It Matters: Biden&#8217;s reform proposal comes amid increasing pressure from his party to make sweeping changes to the Supreme Court. This follows a series of defeats, including the<a href="https://www.benzinga.com/general/politics/23/07/33119984/biden-under-pressure-to-overhaul-supreme-court-as-trump-appointed-justices-help-overturn-fundame"> court's decision to strike down</a> his administration's plan to cancel student debt. The court has significantly shifted towards conservatism following the tenure of former President Donald Trump, who nominated three justices during his time in office.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39999519/trump-vs-harris-latest-survey-indicates-positive-signs-for-this-candidate?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Vs. Harris: Latest Survey Indicates Positive Signs For This Candidate</a></li>
</ul>
Image via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Politics

General

After Trump's Immunity Ruling, Biden Unveils Plan To Reform Supreme Court With Term Limits And Ethics Code

LGVN: &nbsp;49% &#x7C; <a href="https://www.benzinga.com//node/40002230">Longeveron Announced Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B In Mild Alzheimer's Disease; Study Meets Its Key Objectives To Advance Data Supporting Favorable Benefit/Risk Profile</a>
&nbsp;
PHG: 11% &#x7C; <a href="https://www.benzinga.com//node/40003536">Koninklijke Philips Q2 2024 Adj EPS €0.30 Beats €0.25 Estimate, Sales €4.462B Beat €4.430B Estimate</a>
&nbsp;
LIPO: &nbsp;204% &#x7C; <a href="https://www.benzinga.com//node/40005335">Lipella Pharmaceuticals Commences Phase 2a Trial For LP-310 In Oral Lichen Planus, Enrolls First Patients</a>

LGVN

LIPO

Market-Moving News for July 29th

WIIM

VTVT

vTv Therapeutics shares are trading lower after the company announced the FDA has placed a clinical hold on the cadisegliatin clinical program.

CPTN

Cepton shares are trading higher after the company announced it will be acquired by Koito for $3.17 per share in cash.

William Blair analyst Brian Drab initiates coverage on Modine Manufacturing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOD#NYSE">MOD</a>) with a Outperform rating.

Initiation

Analyst Ratings

William Blair Initiates Coverage On Modine Manufacturing with Outperform Rating

Truist Securities analyst Keith Hughes maintains Mohawk Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) with a Buy and raises the price target from $135 to $184.

Price Target

Truist Securities Maintains Buy on Mohawk Industries, Raises Price Target to $184

AMC Entertainment Says This Past Thursday Through Sunday Set Record 2024 Weekend Attendance And Admissions Revenue At Its US Theaters

Full Year 2024&nbsp;Outlook
<ul>
<li>Revenue of&nbsp;$2.5&nbsp;to&nbsp;$2.7 billion</li>
<li>Adjusted EBITDA margin percentage of&nbsp;9.0%&nbsp;to&nbsp;9.6%</li>
<li>Net capital expenditures of&nbsp;$90&nbsp;to&nbsp;$99 million</li>
</ul>

Earnings

Guidance

CTRI

Centuri Initiates 2024 Guidance: Expects Revenue Of $2.5B-$2.7B Vs. $2.877B Est.; Sees Adjusted EBITDA Margin Of 9%-9.6%

Genpact's deep domain knowledge and data expertise enables embecta's vision to make a meaningful impact in the healthcare sector
NEW YORK, July 29, 2024 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4220850-1&amp;h=1902206349&amp;u=https%3A%2F%2Fwww.genpact.com%2F%3Futm_source%3Dggl%26utm_medium%3Dcpc%26utm_campaign%3D4742272061%26gclid%3DCjwKCAjwgdayBhBQEiwAXhMxtmkQxe9rRGSuwgRGZX_ft9X5PLiFgQ_Uha6gpk0TEnRuF4cb_uwCJhoCeGwQAvD_BwE&amp;a=Genpact">Genpact</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>), a global professional services and solutions firm delivering outcomes that shape the future, has been working&nbsp;with&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4220850-1&amp;h=1429926164&amp;u=https%3A%2F%2Fwww.embecta.com%2Fen-us%2F&amp;a=embecta">embecta</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMBC#NASDAQ">EMBC</a>), a global diabetes care company, to support its spin-off from Becton Dickinson and Company (BD) and subsequent evolution as an independent leader in the diabetes technology market.

EMBC

Genpact Has Been Working With embecta's To Support Its Spin-Off Into An Independent Diabetes Care Company

Truist Securities analyst Jordan Levy maintains NEXTracker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) with a Buy and lowers the price target from $70 to $65.

Truist Securities Maintains Buy on NEXTracker, Lowers Price Target to $65

<a href="https://www.globenewswire.com/Tracker?data=Ru8fqsZhLFqPgdBVQWfW8SQo5ubbmzZknojpTn6lBIv59TZPj4INHZgaXIGNfFZF-e28t3dCgVkurVBfvLYL3w==">Cerence Inc.</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNC#NASDAQ">CRNC</a>), AI for a world in motion, today announced its collaboration with <a href="https://www.globenewswire.com/Tracker?data=BLdmGdJcBfXzg2p6Op-v10rb7muqVAKoV43V-dIQnW1w7ICaemBNr5W_jTzGeGSe9F_3jL6TJxT6L2SP_29F8HASweTm-M9ZKD2yzBdd-eg=">smart</a>, the new-premium all-electric automobile brand, on the development of AI-powered solutions for smart's next-generation in-car experiences, first available in the <a href="https://www.globenewswire.com/Tracker?data=C3onjwH1m4wAdB4ugZTjXYxlAq6Wu4UWKklCOPG1DBsY_c1xjBkkfND_gHQqAnLMFlVhDxX2Vr7Ul2-lZfTtqiVxvpqovofQH1LUWn6kxCFXa_5cOWiA8ywvQqj6u1EL261GtMFObp65cD2f0VWq4XQlmHPKN3khXJtq-1mZMmaVGbFYUklLrxuG7xto_SvCLrfWo2QcGzDOhpcQ4T2gYw==">Concept #5</a>. smart has always kept a keen focus on emerging technology and remained at the forefront of exploring the best solutions for future urban mobility. In the AI era and with the support of Cerence, smart will create a new generation of future-proof, convenient and sustainable solutions for customers, ensuring an outstanding user experience and setting new industry benchmarks in Europe and other overseas markets outside Mainland China.

Global

CRNC

smart And Cerence Collaborate To Create Next-Gen, Generative AI-Powered In-Car Experience And Setting New Industry Benchmarks In Europe And Other Overseas Markets Outside Mainland China

Lake Street analyst Ryan Meyers initiates coverage on GigaCloud Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>) with a Buy rating and announces Price Target of $50.

Lake Street Initiates Coverage On GigaCloud Tech with Buy Rating, Announces Price Target of $50

Truist Securities analyst Jordan Levy maintains Sunnova Energy Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) with a Buy and raises the price target from $9 to $10.

NOVA

Truist Securities Maintains Buy on Sunnova Energy Intl, Raises Price Target to $10

Asset Entities Inc.&nbsp;("Asset Entities" or "the Company") (NASDAQ:<a href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>), a provider of digital marketing and content delivery services across Discord and other social media platforms, and a Ternary Payment Platform company, today announced that the Company received formal notice (the "Notice") from the Nasdaq Office of General Counsel of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule").

ASST

Asset Entities Regains Compliance With Nasdaq

Centuri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRI#NYSE">CTRI</a>) reported quarterly earnings of $0.20 per share which missed the analyst consensus estimate of $0.22 by 9.09 percent. The company reported quarterly sales of $672.075 million which missed the analyst consensus estimate of $760.424 million by 11.62 percent. This is a 16.59 percent decrease over sales of $805.779 million the same period last year.

Earnings Misses

Centuri Holdings Q2 2024 Adj EPS $0.20 Misses $0.22 Estimate, Sales $672.075M Miss $760.424M Estimate

Truist Securities analyst Michael Roxland maintains Weyerhaeuser (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WY#NYSE">WY</a>) with a Hold and lowers the price target from $32 to $31.

Truist Securities Maintains Hold on Weyerhaeuser, Lowers Price Target to $31

Wedbush analyst Richard Anderson maintains Healthpeak Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>) with a Outperform and raises the price target from $22 to $25.

Wedbush Maintains Outperform on Healthpeak Properties, Raises Price Target to $25

- Baseline data from the AscenD-LB Phase 2a trial in DLB demonstrated that plasma glial fibrillary acidic protein (GFAP) was highly correlated to scores on the CDR-SB; plasma GFAP shown to increase with neurodegenerative progression in DLB – &nbsp;
- AscenD-LB Phase 2a results demonstrated neflamapimod treatment led to significant reduction compared to placebo in plasma GFAP levels in patients with DLB and the effects of neflamapimod on plasma GFAP were associated with improvement in CDR-SB -
BOSTON, July 29, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that plasma biomarker data from the AscenD-LB Phase 2a trial of neflamapimod in patients with dementia with Lewy bodies (DLB), was featured in a poster presentation at the Alzheimer's Association International Conference&#xAE; (AAIC), being held in Philadelphia from July 28-August 1, 2024.

Biotech

CRVO

CervoMed Presents On Plasma Biomarker Data, Consistent With Neflamapimod Impacting The Underlying Disease Process In Patients With Dementia With Lewy bodies At AAIC 2024

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Searchlight Res

News

Latest news for Searchlight Res (OTC:SCLTF) Stock